IMC Chicago’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2M Sell
139,900
-49,500
-26% -$4.08M ﹤0.01% 1180
2025
Q4
$16.1M Buy
189,400
+35,300
+23% +$2.9M 0.01% 951
2025
Q3
$12M Buy
154,100
+38,400
+33% +$3M ﹤0.01% 1052
2025
Q2
$9.05M Buy
115,700
+16,500
+17% +$1.23M ﹤0.01% 1061
2025
Q1
$7.19M Sell
99,200
-47,700
-32% -$3.41M ﹤0.01% 1034
2024
Q4
$10.9M Buy
146,900
+500
+0.3% +$35K 0.01% 872
2024
Q3
$9.66M Buy
146,400
+59,100
+68% +$4.29M 0.01% 841
2024
Q2
$8.06M Buy
87,300
+6,600
+8% +$584K ﹤0.01% 862
2024
Q1
$7.71M Buy
80,700
+25,700
+47% +$2.16M ﹤0.01% 806
2023
Q4
$4.19M Buy
55,000
+8,300
+18% +$578K ﹤0.01% 934
2023
Q3
$3.24M Buy
46,700
+33,700
+259% +$2.71M ﹤0.01% 848
2023
Q2
$1.23M Buy
+13,000
New +$1.13M ﹤0.01% 1005
2022
Q4
Sell
-12,900
Closed -$1.07M 1276
2022
Q3
$1.07M Buy
+12,900
New +$1.24M ﹤0.01% 912
2021
Q1
Sell
-17,100
Closed -$1.56M 1081
2020
Q4
$1.56M Sell
17,100
-2,500
-13% -$207K ﹤0.01% 774
2020
Q3
$1.56M Sell
19,600
-6,200
-24% -$484K ﹤0.01% 634
2020
Q2
$1.78M Sell
25,800
-15,300
-37% -$1.09M ﹤0.01% 587
2020
Q1
$2.58M Buy
+41,100
New +$2.96M 0.01% 454
2019
Q1
Sell
-12,900
Closed -$659K 717
2018
Q4
$659K Buy
+12,900
New +$653K ﹤0.01% 539

Other funds holding EW

IMC Chicago's EW Position: Q1 2026 in Review

IMC Chicago opened a new position in Edwards Lifesciences (EW) in Q1 2026: 9,445 shares worth $756K. The stake represents ﹤0.01% of the portfolio and ranks #3572 among its holdings. This is a return to the name: IMC Chicago previously reported a position in EW as recently as Q2 2025.

IMC Chicago first reported a position in EW in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.92M in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • IMC Chicago held 9,445 shares of Edwards Lifesciences worth $756K as of Q1 2026.
  • Edwards Lifesciences was a new IMC Chicago position in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3572 holding.
  • IMC Chicago first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 4 quarters since.
  • IMC Chicago's Edwards Lifesciences position peaked at $1.92M in Q2 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.